COVID-19: неврологические последствия

Автор: Спенсер П.С., Роман Г., Бюге А., Гехт А., Рейс Ж.

Журнал: Анализ риска здоровью @journal-fcrisk

Рубрика: Аналитические обзоры

Статья в выпуске: 2 (34), 2021 года.

Бесплатный доступ

Резюме: COVID-19 - это, в первую очередь, респираторное заболевание человека, вызываемое коронавирусом SARS-CoV-2. Но в большинстве случаев оно затрагивает и нервную систему: его последствия могут ощущаться в течение многих месяцев. Последствия острой фазы заболевания COVID-19 - ослабевающие и возвращающиеся неврологические и нервно-психиатрические симптомы как у детей, так и у взрослых, включая и тех, кто переболел в довольно легкой форме. Вследствие того, что длительное негативное воздействие COVID-19 на центральную и периферийную нервную систему невозможно игнорировать, необходимо осуществлять мониторинг здоровья как бывших пациентов, так и общества в целом. В настоящее время актуальными являются не только глобальная иммунизация против SARS-CoV-2, но и возобновление прекращенных программ массовой вакцинации против других вирусных заболеваний (например кори и полиомиелита), которые могут оказывать воздействие на нервную систему.

Еще

Sars-cov-2, pasc: постковидный синдром (длительный covid-19), вакцины

Короткий адрес: https://readera.org/142229601

IDR: 142229601   |   DOI: 10.21668/health.risk/2021.2.16

Список литературы COVID-19: неврологические последствия

  • The proximal origin of SARS-CoV-2 / K.G. Andersen, A. Rambaut, W.I. Lipkin, E.C. Holmes, R.F. Garry // Nat Med. -2020. - Vol. 26, № 4. - P. 450-452. DOI: 10.1038/s41591-020-0820-9
  • Lawrence S.V. COVID-19 and China: A Chronology of Events (December 2019-January 2020). - USA: Congressional Research Service, 2020. - 47 p.
  • Lu D. The hunt to find the coronavirus pandemic's patient zero // New. Sci. - 2020. - Vol. 4, № 245. - P. 9. DOI: 10.1016/S0262-4079(20)30660-6
  • Timing the SARS-CoV-2 index case in Hubei Province / J. Pekar, M. Worobey, N. Moshiri, K. Scheffler, J.O. Wertheim // Science. - 2021. - № 372. - P. 412-417. DOI: 10.1126/science.abf8003
  • History of the COVID-19 pandemic: Origin, explosion, worldwide spreading / S. Platto, Y. Wang, J. Zhou, E. Carafoli // Biochem. Biophys. Res. Commun. -2021. - № 538. - P. 14-23. DOI: 10.1016/j.bbrc.2020.10.087
  • Platto S., Xue T., Carafoli E. COVID19: an announced pandemic // Cell. Death. Dis. - 2020. - № 11. - P. 799. DOI: 10.1038/s41419-020-02995-9
  • Zaheer A. The first 50 days of COVID-19: A detailed chronological timeline and extensive review of literature documenting the pandemic // Surveying the COVID-19 Pandemic and its implications. - 2020. - P. 1-7. DOI: 10.1016/B978-0-12-824313-8.00001-2
  • Bat coronaviruses in China / Y. Fan, K. Zhao, Z.L. Shi, P. Zhou // Viruses. - 2019. - Vol. 11, № 3. - P. 210. DOI: 10.3390/v1103021
  • The spatial and cell-type distribution of SARS-CoV-2 Receptor ACE2 in the human and mouse brains / R. Chen, K. Wang, J. Yu, D. Howard, L. French, Z. Chen, C. Wen, Z. Xu // Front. Neurol. - 2021. - Vol. 20, № 11. - P. 573095. DOI: 10.3389/fneur.2020.573095
  • SARS-CoV-2 dissemination through peripheral nerves explains multiple organ injury / M. Fenrich, S. Mrdenovic, M. Balog, S. Tomic, M. Zjalic, A. Roncevic, D. Mandic, Z. Debeljak, M. Heffer // Front. Cell. Neurosci. - 2020. - Vol. 5, № 14. - 229. DOI: 10.3389/fncel.2020.00229
  • Holappa M., Vapaatalo H., Vaajanen A. Many faces of renin-angiotensin system - focus on eye // Open Ophthalmol. J. -2017. - № 11. - P. 122-142. DOI: 10.2174/1874364101711010122
  • Beneficial Effect of Mas Receptor Deficiency on Vascular Cognitive Impairment in the Presence of Angiotensin II Type 2 Receptor / A. Higaki, M. Mogi, J. Iwanami, L.-J. Min, H.-Y. Bai, B.-S. Shan, M. Kukida, T. Yamauchi [et al.] // J. Am. Heart. Assoc. - 2018. - Vol. 7, № 3. - P. e008121. DOI: 10.1161/JAHA.117.008121
  • Body localization of ACE-2: On the trail of the keyhole of SARS-CoV-2 / F. Salamanna, M. Maglio, M.P. Landini, M. Fini // Front. Med. (Lausanne). - 2020. - Vol. 3, № 7. - P. 594495. DOI: 10.3389/fmed.2020.594495
  • Deficiency of angiotensin-converting enzyme 2 causes deterioration of cognitive function / X.L. Wang, J. Iwanami, L.J. Min, K. Tsukuda, H. Nakaoka, H.-Y. Bai, B.-S. Shan, H. Kan-No [et al.] // NPJ Aging. Mech. Dis. - 2016. - Vol. 20, № 2. - P. 16024. DOI: 10.1038/npjamd.2016.24
  • Analysis of risk actors in COVID-19 adult mortality in Russia / Y. Kirillov, S. Timofeev, A. Avdalyan, V.N. Nikolenko, L. Gridin, M.Y. Sinelnikov // J. Prim. Care. Community. Health. - 2021. - Vol. 12. - P. 21501327211008050. DOI: 10.1177/21501327211008050
  • Comorbidity and its impact on patients with COVID-19 / A. Sanyaolu, C. Okorie, A. Marinkovic, R. Patidar, K. Younis, P. Desai, Z. Hosein, I. Padda [et al.] // SN Compr. Clin. Med. - 2020. - Vol. 25. - P. 1-8. DOI: 10.1007/s42399-020-00363-4
  • The pivotal link between ACE2 deficiency and SARS-CoV-2 infection / P. Verdecchia, C. Cavallini, A. Spanevello, A. Fabio // Eur. J. Intern. Med. - 2020. - Vol. 76. - P. 14-20. DOI: 10.1016/j.ejim.2020.04.037
  • Interactions of SARS-CoV-2 with the blood-brain barrier / M.A. Erickson, E.M. Rhea, R.C. Knopp, W.A. Banks // Int. J. Mol. Sci. - 2021. - Vol. 6, № 22 (5). - P. 2681. DOI: 10.3390/ijms22052681
  • Alomari S., Abou-Mrad Z., Bydon A. COVID-19 and the central nervous system // Clin. Neurol. Neurosurg. - 2020. -Vol. 198. - P. 106116. DOI: 10.1016/j.clineuro.2020.106116
  • Neurological associations of COVID-19 / M.A. Ellul, L. Benjamin, B. Singh, S. Lant, B.D. Michael, A. Easton, R. Kneen, S. Defres [et al.] // Lancet Neurol. - 2020. - Vol. 19, № 9. - P. 767-783. DOI: 10.1016/S1474-4422(20)30221-0
  • El-Sayed A., Aleya L., Kamel M. COVID-19: a new emerging respiratory disease from the neurological perspective // Environ. Sci. Pollut. Res. Int. - 2021. - Vol. 15. - P. 1-15. DOI: 10.1007/s11356-021-12969-9
  • Frequent neurologic manifestations and encephalopathy-associated morbidity in COVID-19 patients / E.M. Liotta, A. Batra, J.R. Clark, N.A. Shlobin, S.C. Hoffman, Z.S. Orban, I.J. Koralnik [et al.] // Ann. Clin. Transl. Neurol. - 2020. -Vol. 7, № 11. - P. 2221-2230. DOI: 10.1002/acn3.51210
  • Central nervous system manifestations in COVID-19 patients: A systematic review and meta-analysis / S. Nazari, A. Azari Jafari, S. Mirmoeeni, S. Sadeghian, M. Eghbal Heidari, S. Sadeghian, F. Assarzadegan, S. Mahmoud Puormand [et al.] // Brain Behav. - 2021. - P. e02025. DOI: 10.1002/brb3.2025
  • Decade of progress in motor functional neurological disorder: continuing the momentum / D.L. Perez, M.J. Edwards, G. Nielsen, K. Kozlowska, M. Hallett, W. Curt LaFrance Jr. // J. Neurol. Neurosurg. Psychiatry. - 2021. - Vol. 92, № 6. - P. 668-667. DOI: 10.1136/jnnp-2020-323953
  • Psychological morbidities and fatigue in patients with confirmed COVID-19 during disease outbreak: prevalence and associated biopsychosocial risk factors / R. Qi, W. Chen, S. Liu, P.M. Thompson, L.J. Zhang, F. Xia, F. Cheng, A. Hong [et al.] // medRxiv. - 2020. - № 11. - P. 1-21. DOI: 10.1101/2020.05.08.20031666
  • The neurology of COVID-19 revisited: A proposal from the Environmental Neurology Specialty Group of the World Federation of Neurology to implement international neurological registries / G.C. Román, P.S. Spencer, J. Reis, A. Buguet, M. El Alaoui Faris, S.M. Katrak, M. Láinez, M. Tulio Medina [et al.] // J. Neurol. Sci. - 2020. - Vol. 15, № 414. - P. 116884. DOI: 10.1016/j.jns.2020.116884
  • Neurological involvement in the respiratory manifestations of COVID-19 patients / B.H. Tan, J.M. Liu, Y. Gui, S. Wu, J.-L. Suo, Y.-C. Li // Aging (Albany NY). - 2021. - Vol. 14, № 13 (3). - P. 4713-4730. DOI: 10.18632/aging.202665
  • Wildwing T., Holt N. The neurological symptoms of COVID-19: a systematic overview of systematic reviews, comparison with other neurological conditions and implications for healthcare services // Ther. Adv. Chronic. Dis. - 2021. -Vol. 12. - P. 2040622320976979. DOI: 10.1177/2040622320976979
  • Epilepsy course during COVID-19 pandemic in three Italian epilepsy centers / C. Cabona, F. Deleo, L. Marinelli, D. Audenino, D. Arnaldi, F. Rossi, R. Di Giacomo, C. Buffoni [et al.] // Epilepsy Behav. - 2020. - Vol. 112. - P. 107375. DOI: 10.1016/j.yebeh.2020.107375
  • Эпилепсия и COVID-19: ведение больных и оптимизация противоэпилептической терапии в условиях пандемии / Ф.К. Ридер, А.В. Лебедева, В.Р. Мкртчян, А.Б. Гехт // Журнал неврологии и психиатрии им. С.С. Корсакова. - 2020. - Vol. 120, № 10. - P. 100-107.
  • Prognostic indicators and outcomes of hospitalised COVID-19 patients with neurological disease: A systematic review and individual patient data meta-analysis / B. Singh, S. Lant, S. Cividini, J.W.S. Cattrall, L. Goodwin, L. Benjamin, B. Michael, A. Khawaja [et al.] // Lancet. - 2021. - Vol. 27. - P. 95. DOI: 10.21.2139/ssrn.3834310
  • Azghandi M., Kerachian M.A. Detection of novel coronavirus (SARS-CoV-2) RNA in peripheral blood specimens // J. Transl. Med. - 2020. - № 18. - P. 412. DOI: 10.1186/s12967-020-02589-1
  • Neuropathology of COVID-19 (neuro-COVID): clinicopathological update / J.J. Lou, M. Movassaghi, D. Gordy, M.G. Olson, T. Zhang, M.S. Khurana, Z. Chen, M. Perez-Rosendahl [et al.] // Free Neuropathol. - 2021. - Vol. 2, № 2. DOI: 10.17879/freeneuropathology-2021-2993
  • Cerebrospinal fluid findings in COVID-19 patients with neurological symptoms / B. Neumann, M.L. Schmidbauer, K. Dimitriadis, S. Otto, B. Knier, W.-D. Niesen, J.A. Hosp, A. Günther [et al.] // J. Neurol. Sci. - 2020. - Vol. 15, № 418. -P. 117090. DOI: 10.1016/j.jns.2020.117090
  • Detection of SARS-CoV-2 in different types of clinical specimens / W. Wang, Y. Xu, R. Gao, R. Lu, K. Han, G. Wu, W. Tan // JAMA. - 2020. - Vol. 12, № 323 (18). - P. 1843-1844. DOI: 10.1001/jama.2020.3786
  • Microvascular injury in the brains of patients with COVID-19 / M.H. Lee, D.P. Perl, G. Nair, W. Li, D. Maric, H. Murray, S.J. Dodd, A.P. Koretsky [et al.] // N. Engl. J. Med. - 2021. Vol. 4, № 384 (5). - P. 481-483. DOI: 10.1056/NEJMc2033369
  • Neuropathology of patients with COVID-19 in Germany: a post-mortem case series / J. Matschke, M. Lütgehetmann, C. Hagel, J.P. Sperhake, A.S. Schröder, C. Edler, H. Mushumba, A. Fitzek [et al.] // Lancet Neurol. - 2020. - Vol. 19, № 11. -P. 919-929. DOI: 10.1016/S1474-4422(20)30308-2
  • Brundin P., Nath A., Beckham J.D. Is COVID-19 a perfect storm for Parkinson's Disease? // Trends Neurosci. - 2020. -№ 43. - P. 931-933. DOI: 10.1016/j.tins.2020.10.009
  • Al-Aly Z., Xie Y., Bowe B. High-dimensional characterization of post-acute sequalae of COVID-19 // Nature. - 2021. - Vol. 594, № 7862. - P. 259-264. DOI: 10.1038/s41586-021-03553-9
  • Carfi A., Bernabei R., Landi F. for the Gemelli Against COVID-19 Post-Acute Care Study Group. Persistent symptoms in patients after acute COVID-19 // JAMA. - 2020. - Vol. 11, № 324 (6). - P. 603-605. DOI: 10.1001/jama.2020.12603
  • Miners S., Kehoe P.G., Love S. Cognitive impact of COVID-19: looking beyond the short term // Alzheimers. Res. Ther. - 2020. - № 12. - P. 170. DOI: 10.1186/s13195-020-00744-w
  • Acute Transverse Myelitis (ATM): Clinical review of 43 patients with COVID-19-associated ATM and 3 post-vaccination ATM serious adverse events with the ChAdOxl nCoV-19 Vaccine (AZD1222) I G.C. Román, F. Gracia, A. Torres, A. Palacios, K. Gracia, D. Harris [et al.] II Front Immunol. - 2021. - Vol. 26, i 12. - P. 653786. DOI: 103389Ifimmu.2021.653786
  • Multisystem inflammatory syndrome associated with COVID-19 from the pediatric emergency physician's point of view I H. Simon Junior, T.M.S. Sakano, R.M. Rodrigues, A.P. Eisencraft, V.E. Lemos de Carvalho, C. Schvartsman, A.G.A. da Costa Reis II J. Pediatr (Rio J). - 2021. - Vol. 97, M 2. - P. 140-159. DOI: 10.1016Ij.jped.2020.08.004
  • 6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records I M. Taquet, J.R. Geddes, M. Husain, S. Luciano, P.J. Harrison II Lancet Psychiat. - 2021. - M 8. -P. 416-427. DOI: 10.1016Is2215-0366(21)00084-5
  • Risk factors for long-term consequences of COVID-19 in hospitalized adults in Moscow using the ISARIC Global follow-up protocol: Stop COVID cohort study I D. Munblit, P. Bobkov, E. Spiridonova, A. Shikhaleva, A. Gamirova, O. Blyuss, N. Nekliudov, P. Bugaev [et al.] II medRxiv. - 2021. - M 19. - P. 26. DOI: 10.1101I2021.02.17.21251895
  • Torjeson I. Covid-19: Middle aged women face greater risk of debilitating long term symptoms II BMJ. - 2021. -M 372. - P. n829. DOI: 10.1136Ibmj.n829
  • Baig A.M. Chronic COVID syndrome: Need for an appropriate medical terminology for long-COVID and COVID long-haulers II J. Med. Virol. - 2021. - M 93. - P. 2555-2556. DOI: 10.1002Ijmv.26624
  • Defining Post-COVID Symptoms (Post-Acute COVID, Long COVID, Persistent Post-COVID): An integrative classification I C. Fernández-de-Las-Peñas, D. Palacios-Ceña, V. Gómez-Mayordomo, M.L. Cuadrado, L.L. Florencio II Int. J. Environ. Res. Public. Health. - 2021. - M 18. - P. 2621. DOI: 10.3390Iijerph18052621
  • Moldofsky H., Patcai J. Chronic widespread musculoskeletal pain, fatigue, depression and disordered sleep in chronic post-SARS syndrome; a case-controlled study II BMC Neurol. - 2011. - Vol. 24, M 11. - P. 37. DOI: 10.1186I1471-2377-11-37
  • Autonomic dysfunction in 'long COVID': rationale, physiology and management strategies I M. Dani, A. Dirksen, P. Taraborrelli, M. Torocastro, D. Panagopoulos, R. Sutton, P.B. Lim II Clin. Med. J. - 2021. - M 21. - P. e63-e67. DOI: 10.7861Iclinmed.2020-089
  • Wijeratne T., Crewther S. Post-COVID 19 Neurological Syndrome (PCNS); a novel syndrome with challenges for the global neurology community II J Neurol Sci. - 2020. - M 419. - P. 117179. DOI: 10.1016Ij.jns.2020.117179
  • Sars-Cov-2: Underestimated damage to nervous system I L. Zhou, M. Zhang, J. Wang, J. Gao II Travel. Med. Infect. Dis. - 2020. - M 36. - P. 101642. DOI: 10.1016Ij.tmaid.2020.101642
  • Hawkes C. Olfaction in neurodegenerative disorder II Adv Otorhinolaryngol. - 2006. - M 63. - P. 133-151. DOI: 10.1159I000093759
  • APOE e4 Genotype predicts severe COVID-19 in the UK Biobank Community Cohort I C.L. Kuo, L.C. Pilling, J.L. Atkins, J.A.H. Masoli, J. Delgado, G.A. Kuchel, D. Melzer II J. Gerontol. A. Biol. Sci. Med. Sci. - 2020. - Vol. 15, M 75 (11). - P. 2231-2232. DOI: 10.1093IgeronaIglaa131
  • ApoE-isoform-dependent SARS-CoV-2 neurotropism and cellular response I C. Wang, M. Zhang, G. Garcia Jr, E. Tian, Q. Cui, X. Chen, G. Sun, J. Wang [et al.] II Cell. Stem. Cell. - 2021. - M 28. - P. 331-342.e5. DOI: 10.1016Ij.stem.2020.12.018
  • Outbreak of Marburg virus disease in Johannesburg I J.S. Gear, G.A. Cassel, A.J. Gear, B. Trappler, L. Clausen, A.M. Meyers, M.C. Kew, T.H. Bothwell [et al.] II Br. Med. J. - 1975. - Vol. 29, M 4. - P. 489-493. DOI: 10.1136Ibmj.4.5995.489
  • Van Gelder R.N., Margolis T.P. Ebola and the ophthalmologist II Ophthalmology. - 2015. - M 122. - P. 2152-2154. DOI: 10.1016Ij.ophtha.2015.08.027
  • Persistence of Ebola Virus in ocular fluid during convalescence I J.B. Varkey, J.G. Shantha, I. Crozier, C.S. Kraft, G.M. Lyon, A.K. Mehta, G. Kumar, J.R. Smith [et al.] II N. Engl. J. Med. - 2015. - M 372. - P. 2423-2427. DOI: 10.1056INEJMoa1500306
  • A dangerous measles future looms beyond the COVID-19 pandemic I D.N. Durrheim, J.K. Andrus, S. Tabassum, H. Bashour, D. Githanga, G. Pfaff [et al.] II Nat. Med. - 2021. - Vol. 27, M 3. - P. 360-361. DOI: 10.1038Is41591-021-01237-5
  • Fading measles immunity over time. Center for Infectious Disease Research and Policy [Электронный ресурс] II CIDRAP. - URL: https:IIwww.cidrap.umn.edu/news-perspectiveI2020I09Inews-scan-sep-02-2020 (дата обращения: 03.04.2021).
  • Impact of COVID-19 on routine immunisation in South-East Asia and Western Pacific: Disruptions and solutions I R.C. Harris, Y. Chen, P. Côte, A. Ardillon, M.C. Nievera, A. Ong-Lim, S. Aiyamperumal, C.P. Chong [et al.] II Lancet. Reg. Health. West. Pac. - 2021. - M 10. - P. 100140. DOI: 10.1016Ij.lanwpc.2021.100140
  • The upsurge of SSPE--a reflection of national measles immunization status in Pakistan I S.H. Ibrahim, N. Amjad, A.F. Saleem, P. Chand, A. Rafique, K. Nuzhat Humayun II J. Trop. Pediatr. - 2014. - Vol. 60, M 6. - P. 449-453. DOI: 10.1093ItropejIfmu050
  • Human coronaviruses and other respiratory viruses: Underestimated opportunistic pathogens of the central nervous system? I M. Desforges, A. Le Coupanec, P. Dubeau, A. Bourgouin, L. Lajoie, M. Dubé, P.J. Talbot II Viruses. - 2019. -Vol. 20, M 12 (1). - P. 14. DOI: 10.3390Iv12010014
  • Axonal transport enables neuron-to-neuron propagation of human coronavirus OC43 I M. Dubé, A. Le Coupanec, A.H.M. Wong, J.M. Rini, M. Desforges, P.J. Talbot II J. Virol. - 2018. - Vol. 16, M 92 (17). - P. e00404-18. DOI: 10.1128IJVI.00404-18
Еще
Статья обзорная